Top Markets
Coin of the day
TWi Biotechnology, Inc. TWi Biotechnology, Inc.

TWi Biotechnology, Inc.

6610
Rank in Stocks #17313
TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm,... TWi Biotechnology, Inc. operates as a clinical-stage biopharmaceutical firm, concentrating on the development and sale of medications designed to address innate immunity disorders, primarily within Taiwan. The company's drug pipeline notably includes AC-203, which is currently undergoing Phase 2 clinical trials for various conditions such as epidermolysis bullosa simplex, epidermolysis bullosa, arthritis, gout, and diabetes mellitus. Additionally, AC-1101 is in Phase 1 trials for vitiligo treatment and is advancing through preclinical stages for atopic dermatitis, granuloma annulare, and other uncommon autoimmune skin diseases. TWi Biotechnology has also established a drug development collaboration with Hong Kong Winhealth Pharma Group Co., Limited, targeting the markets of Mainland China, Hong Kong, and Macao. Founded in 2010, the company is headquartered in Taipei, Taiwan.
Share Price
$1.21
Market Cap
$248.41M
Change (1 day)
4.11%
Change (1 year)
79.12%
Country
TW
Trade TWi Biotechnology, Inc. (6610)

Category

Stock price history for TWi Biotechnology, Inc. (6610)
Highest end of day price: $1.18 on 2026-09-01

Lowest end of day price: $1.95 on 2016-12-01
Stock price history of TWi Biotechnology, Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 43.11%
2025 36.47%
2024 -13.49%
2023 13.07%
2022 -19.33%
2021 0.82%
2020 81.49%
2019 -54.47%
2018 -43.81%
2017 -42.56%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$550.56 37.30%
US
$1.05K 47.97%
NL
$122.21 -10.03%
AU
$146.95 507.48%
US
$757.71 8.20%
CH